Blood tests to estimate lung cancer risk over 3 years
Part of Cancer, Lungs & breathing clinical trials.
This study looks for blood “biomarkers” (measurable signs in blood) that may help predict who is at higher or lower risk related to lung cancer. You would have blood samples taken and then be followed with visits for up to 3 years.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 40 or older
- Be able to understand the study and sign written consent
- Be willing to follow the study schedule and provide blood samples
- Be willing to complete 3 years of follow-up visits
- Have no other active cancer in the last 5 years
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses advanced gene sequencing technology on blood and tumor tissue samples from people with non-small cell lung cancer. The goal is to see if this testing can help doctors better predict which treatments will work and detect if the cancer comes back early.
This study tests a new blood test that looks for lung cancer DNA. It may help find lung cancer early, especially in people at higher risk.
This study uses a blood test to look for tiny genetic markers (miRNA and DNA methylation) that may help detect lung cancer early. If you have a lung nodule or mass found on a CT scan and haven't had treatment yet, you may be able to join.
This study is evaluating a blood-based test that might detect lung cancer early, before symptoms appear. Researchers are looking for heavy smokers who have no signs of cancer, as well as those with suspicious lung nodules or confirmed lung cancer, to see if a simple blood draw could help identify cancer sooner.
This study aims to see if a blood test can tell if a lung nodule is cancerous or not. It may help doctors avoid unnecessary procedures.
This study tests a blood test that looks for DNA changes from lung cancer. It aims to find out if the test can help tell whether a lung nodule is cancer or not, so that people might avoid unnecessary procedures.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.